Shanghai, China

Yueqing Xie

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yueqing Xie in Polypeptide Composition and Tumor Immunotherapy

Introduction

Yueqing Xie is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide compositions and their applications in tumor immunotherapy. With a total of two patents to his name, Xie's work is paving the way for advancements in cancer treatment.

Latest Patents

Yueqing Xie's latest patents include a polypeptide composition that features a first polypeptide and a second polypeptide. The first polypeptide comprises a first toxin fragment and a first intein fragment, while the second polypeptide includes a second toxin fragment and a second intein fragment. Notably, the first and second toxin fragments are non-biotoxic, and through the interaction of the intein fragments, they can be transformed into biotoxic toxins. This innovative composition has potential applications in treating tumors. Another significant patent involves a polypeptide combination used for tumor immunotherapy. This combination includes a targeting component with a shielding peptide, a cleavable part, an antigen-binding part, and a first intein fragment. The immunoconjugate formed by the interaction of the intein fragments allows for targeted delivery of toxins to cancer cells, enhancing therapeutic efficacy.

Career Highlights

Yueqing Xie has worked with reputable organizations such as Jecho Institute, Co., Ltd. and Jecho Laboratories Inc. His experience in these institutions has contributed to his expertise in the field of biotechnology and immunotherapy.

Collaborations

Xie has collaborated with notable colleagues, including Jianwei Zhu and Jing Wang. These partnerships have likely fostered innovative ideas and advancements in their shared research interests.

Conclusion

Yueqing Xie's contributions to polypeptide compositions and tumor immunotherapy represent a significant advancement in cancer treatment. His innovative patents and collaborations highlight his commitment to improving therapeutic strategies in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…